Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences (2023)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1111/dar.13587
- Subjects: ALUCINOGÊNICOS; TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS; ALCALOIDES; FARMACOTERAPIA
- Keywords: Hallucinogenic; Iboga; Psychedelic; Qualitative analysis; Substance use disorders
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2023
- Source:
- Título: Drug and Alcohol Review
- ISSN: 0959-5236
- Volume/Número/Paginação/Ano: v. 42, n. 2, p. 401-414, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: unspecified-oa
-
ABNT
RODRÍGUEZ‐CANO, Borja J. et al. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, v. 42, n. 2, p. 401-414, 2023Tradução . . Disponível em: https://doi.org/10.1111/dar.13587. Acesso em: 29 dez. 2025. -
APA
Rodríguez‐Cano, B. J., Kohek, M., Ona, G., Alcázar‐Córcoles, M. Á., Santos, R. G. dos, Hallak, J. E. C., & Bouso, J. C. (2023). Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, 42( 2), 401-414. doi:10.1111/dar.13587 -
NLM
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/dar.13587 -
Vancouver
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/dar.13587 - Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Psychedelics in psychiatry
- Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy [Editorial]
- Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects
- Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
- Acute psychological adverse reactions in first-time ritual ayahuasca users: a prospective case series
- Natural hallucinogens in mental health [Editorial]
- Psychedelic medicines in major depression: progress and future challenges
Informações sobre o DOI: 10.1111/dar.13587 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003200950.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
